111 Inc
YI7.395USD
-0.055-0.74%
종가 02/06, 16:00（ET）시세는 15분 지연됩니다
374.74M시가총액
손실P/E TTM
자세한 내용은 111 Inc 회사
111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.
111 Inc 정보
종목 코드 YI
회사 이름111 Inc
상장일Sep 12, 2018
CEOLiu (Junling)
직원 수1238
유형Depository Receipt
회계 연도 종료Sep 12
주소3-4/F, No.295 Zuchongzhi Road
도시SHANGHAI
증권 거래소NASDAQ OMX - NASDAQ BASIC
국가China
우편 번호201203
전화862120536666
웹사이트http://corporate.111.com.cn/
종목 코드 YI
상장일Sep 12, 2018
CEOLiu (Junling)
111 Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
이름
이름/직위
직위
주식 보유
변동
Dr. Gang Yu, Ph.D.
Dr. Gang Yu, Ph.D.
Executive Co-Chairman of the Board, Co-Founder
Executive Co-Chairman of the Board, Co-Founder
--
--
Mr. Junling Liu
Mr. Junling Liu
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
Co-Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Mr. Nee Chuan Teo, CPA
Mr. Nee Chuan Teo, CPA
Independent Director
Independent Director
--
--
Mr. Jian (David) Sun
Mr. Jian (David) Sun
Independent Director
Independent Director
--
--
Mr. Jun Luo
Mr. Jun Luo
Independent Director
Independent Director
--
--
Mr. Yang (Luke) Chen
Mr. Yang (Luke) Chen
Director
Director
--
--
수익 분석
통화: USD마지막 업데이트: Tue, Jan 6
통화: USD마지막 업데이트: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
사업별USD
이름
수익
비율
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
기업이 아직 관련 데이터를 공개하지 않았습니다.
사업별
지역별
사업별USD
이름
수익
비율
Product Revenues
2.98B
99.44%
Service Revenues
16.89M
0.56%
주식 보유 통계
마지막 업데이트: Fri, Jan 30
마지막 업데이트: Fri, Jan 30
주주
주주 유형
주주
주주
비율
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
기타
90.39%
주주
주주
비율
First Pharmacia International
8.57%
Susquehanna International Group, LLP
0.59%
Renaissance Technologies LLC
0.26%
Morgan Stanley & Co. LLC
0.10%
Serenus Wealth Advisors, LLC
0.09%
기타
90.39%
주주 유형
주주
비율
Corporation
8.57%
Investment Advisor
0.68%
Hedge Fund
0.26%
Research Firm
0.10%
Investment Advisor/Hedge Fund
0.05%
기타
90.33%
기관 주식 보유
마지막 업데이트: Wed, Jan 21
마지막 업데이트: Wed, Jan 21
보고 기간
기관 수
보유 주식
비율
변동
2026Q4
25
52.21K
6.89%
--
2025Q4
37
55.41K
1.09%
-397.88K
2025Q3
42
1.21M
23.79%
-403.88K
2025Q2
48
1.99M
39.33%
-416.92K
2025Q1
49
2.00M
39.53%
-387.91K
2024Q4
51
2.26M
44.72%
+133.67K
2024Q3
43
1.99M
39.36%
-280.22K
2024Q2
45
2.17M
42.88%
-87.92K
2024Q1
52
2.15M
42.65%
-125.45K
2023Q4
54
2.16M
44.89%
-28.04K
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
First Pharmacia International
434.53K
8.57%
--
--
Mar 31, 2025
Susquehanna International Group, LLP
29.91K
0.59%
+15.14K
+102.54%
Sep 30, 2025
Renaissance Technologies LLC
13.01K
0.26%
--
--
Sep 30, 2025
Morgan Stanley & Co. LLC
5.14K
0.1%
--
--
Sep 30, 2025
Geode Capital Management, L.L.C.
2.44K
0.05%
--
--
Nov 30, 2025
UBS Financial Services, Inc.
1.45K
0.03%
-4.67K
-76.32%
Sep 30, 2025
SBI Securities Co., Ltd.
184.00
0%
-40.00
-17.86%
Sep 30, 2025
J.P. Morgan Securities LLC
23.00
0%
+15.00
+187.50%
Sep 30, 2025
Parametric Portfolio Associates LLC
27.00
0%
--
--
Sep 30, 2025
더 보기
관련 ETF
마지막 업데이트: Sat, Dec 6
마지막 업데이트: Sat, Dec 6
이름
비율
SPDR S&P Emerging Markets Small Cap ETF
0%
SPDR Portfolio Emerging Markets ETF
0%
SPDR S&P Emerging Asia Pacific ETF
0%
SPDR S&P Emerging Markets Small Cap ETF
비율0%
SPDR Portfolio Emerging Markets ETF
비율0%
SPDR S&P Emerging Asia Pacific ETF
비율0%
주식 배당금
지난 5년 동안 총
0.00
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
데이터 없음
주식 분할
날짜
배당락일
유형
비율
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
날짜
배당락일
유형
비율
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
Jan 03, 2025
Merger
10→1
